Antifungal and antitumor activities of a monoclonal antibody directed against a stress mannoprotein of Candida albicans

被引:22
作者
Omaetxebarría, MJ
Moragues, MD
Elguezabal, N
Rodríguez-Alejandre, A
Brena, S
Schneider, J
Polonelli, L
Pontón, J
机构
[1] Univ Basque Country, Fac Med & Odontol, Dept Microbiol Immunol & Parasitol, E-48080 Bilbao, Spain
[2] Univ Basque Country, Dept Enfermeria, E-48080 Bilbao, Spain
[3] Univ Rey Juan Carlos, Fac Ciencias Salud, Dept Ciencias Salud, Madrid, Spain
[4] Univ Parma, Dipartimento Patol & Med Lab, Sez Microbiol, I-43100 Parma, Italy
关键词
Candida albicans; stress mannoprotein; fungicidal; tumoricidal; monoclonal antibody C7; Nup88; human tumors;
D O I
10.2174/1566524054022521
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Immunization of mice with a stress mannoprotein of > 200 kDa from the cell wall of Candida albicans led to the production of monoclonal antibody (Mab) C7. The immunogen is a major target of secretory IgA and its expression is regulated by different environmental conditions including temperature, pH, glucose concentration and ammonium sulphate in the culture medium. Mab C7 reacted with a peptide-epitope present in the >200 kDa antigen as well as in a number of antigens from the blastoconidium and germ tube cell wall, including enolase. In addition to its reactivity with C. albicans, Mab C7 also reacted with antigens present in C. krusei, C, tropicalis, C. glabrata, C. dubliniensis and C. lusitaniae, as well as in Cryptococcus neoformans, Scedosporium prolificans and Aspergillus fumigatus. Mab C7 exhibited four important biological activities, namely inhibition of adhesion of C. albicans to a variety of surfaces, inhibition of germination of C. albicans, direct candidacidal activity and direct tumoricidal activity. In tumor cells, Mab C7 reacted with nucleoporin Nup88, a reactivity that can be utilized for diagnostic and prognostic purposes.
引用
收藏
页码:393 / 401
页数:9
相关论文
共 68 条
[1]   Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptide antimycotics [J].
Angiolella, L ;
Facchin, M ;
Stringaro, A ;
Maras, B ;
Simonetti, N ;
Cassone, A .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (03) :684-690
[2]  
[Anonymous], 1997, CLIN MICROBIOL REV
[3]   DISTINCT MECHANISMS OF EPITHELIAL ADHESION FOR CANDIDA-ALBICANS AND CANDIDA-TROPICALIS - IDENTIFICATION OF THE PARTICIPATING LIGANDS AND DEVELOPMENT OF INHIBITORY PEPTIDES [J].
BENDEL, CM ;
HOSTETTER, MK ;
MCCLELLAN, M .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) :1840-1849
[4]   Influence of environmental pH on the reactivity of Candida albicans with salivary IgA [J].
Bikandi, J ;
Moragues, MD ;
Quindós, G ;
Polonelli, L ;
Pontón, J .
JOURNAL OF DENTAL RESEARCH, 2000, 79 (06) :1439-1442
[5]   Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated candidiasis in recipients of a Candida albicans vaccine [J].
Bromuro, C ;
Torosantucci, A ;
Chiani, P ;
Conti, S ;
Polonelli, L ;
Cassone, A .
INFECTION AND IMMUNITY, 2002, 70 (10) :5462-5470
[6]  
Casadevall A, 1998, MED MYCOL, V36, P95
[7]   ANTIBODY IMMUNITY AND INVASIVE FUNGAL-INFECTIONS [J].
CASADEVALL, A .
INFECTION AND IMMUNITY, 1995, 63 (11) :4211-4218
[8]   FAB FRAGMENTS FROM A MONOCLONAL-ANTIBODY AGAINST A GERM TUBE MANNOPROTEIN BLOCK THE YEAST-TO-MYCELIUM TRANSITION IN CANDIDA-ALBICANS [J].
CASANOVA, M ;
MARTINEZ, JP ;
CHAFFIN, WL .
INFECTION AND IMMUNITY, 1990, 58 (11) :3810-3812
[9]   Antibodies, killer toxins and antifungal immunoprotection: A lesson from nature [J].
Cassone, A ;
Conti, S ;
DeBernardis, F ;
Polonelli, L .
IMMUNOLOGY TODAY, 1997, 18 (04) :164-169
[10]   Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation [J].
Cenci, E ;
Mencacci, A ;
Spreca, A ;
Montagnoli, C ;
Bacci, A ;
Perruccio, K ;
Velardi, A ;
Magliani, W ;
Conti, S ;
Polonelli, L ;
Romani, L .
INFECTION AND IMMUNITY, 2002, 70 (05) :2375-2382